Grade 1 or 2 HCB sign (vertical or cruciform hyper-intensity) | Grade 2 HCB sign (cruciform hyper-intensity) | |
---|---|---|
MSA-C | 38/41 (92.7%) | 30/41 (73.2%) |
SCA3 | 21/26 (80.8%) | 8/26 (30.8%) |
Controls | 0/22 (0%) | 0/22 (0%) |
P value for group comparison | < 0.001a | < 0.001a |
p value for post-hoc group comparisons | ||
MSA-C vs. SCA3 | 0.141b | 0.001a |
MSA-C vs. Controls | < 0.001a | < 0.001a |
SCA3 vs. Controls | < 0.001a | 0.004b |
MSA-C within 2 years after onset | 22/24 (91.7%) | 13/24 (54.2%) |
SCA3 within 2 years after onset | 2/4 (50.0%) | 0/4 (0%) |
P value | 0.086b | 0.067b |
MSA-C within 3 years after onset | 33/36 (91.7%) | 24/36 (66.7%) |
SCA3 within 3 years after onset | 4/8 (50.0%) | 0/8 (0%) |
P value | 0.014b | 0.001b |